Celerion

Celerion joins Cardiac Safety Research Consortium

Thursday, October 16, 2014

Celerion, a Lincoln, Neb.-based provider of cardiovascular safety services in early clinical research, has become a member of the Cardiac Safety Research Consortium (CSRC). Celerion will engage with other thought leaders on key issues that impact cardiovascular safety, including discussions of alternative approaches to ICH E14 to assess arrhythmia liability in early drug development.

[Read More]

Celerion opens at Seoul National University Hospital Clinical Trial Center

Wednesday, March 5, 2014

Celerion, a provider of early clinical research, has expanded clinical operations to South Korea. Through a partnership with Seoul National University Hospital (SNUH), the new Asian office is located within the SNUH Clinical Trials Center, giving Celerion and its clients access to the 80-bed clinical research unit, particularly geared toward clinical pharmacology, oncology and pediatrics.

[Read More]

Celerion receives ANVISA certification

Friday, June 10, 2011

Lincoln, Neb.-based Celerion, a provider of early-stage drug development solutions, has announced that its clinical research operations in Belfast, Northern Ireland, and its clinical research and bioanalytical services operations in Lincoln, Neb., have been certified by the Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária – ANVISA). 

[Read More]